Helpful Links

Navigate OHIO

About OHIO Admission Athletics
Academics Life at OHIO

Connect With Us

Russ College of Engineering and Technology
Stocker Center
Athens, OH 45701

Stephen Bergmeier

Stephen Bergmeier
Professor, Chemistry and Biochemistry
Clippinger Hall 277
Biomedical Engineering
bergmeis@ohio.edu
740.597.9649
https://www.ohio.edu/chemistry/faculty/bergmeier.php

Research Interests: Drug Design, Drug Synthesis, Pharmaceutical Engineering

All Degrees Earned: Ph.D., Medicinal Chemistry, University of Michigan, 1990.

Journal Article, Academic Journal (39)

  • McCall, K., Walter, D., Patton, A., Thuma, J., Courreges de Benencia, M., Palczewski, G., Goetz, D., Bergmeier, S., Schwartz, F. (2023). Anti-Inflammatory and Therapeutic Effects of a Novel Small-Molecule Inhibitor of Inflammation in a Male C57BL/6J Mouse Model of Obesity-Induced NAFLD/MAFLD. 16. Journal of Inflammation Research; 2023: 5339-5366.
  • Ghazanfari, D., Courreges de Benencia, M., Belinski, L., Lloyd, J., Bergmeier, S., McCall, K., Goetz, D. (2022). Mechanistic Insights into SARS-CoV-2 Spike Protein Induction of the Chemokine CXCL10. Submitted.
  • Ghazanfari, D., Courreges, M., Belinski, L., Bergmeier, S., McCall, K., Goetz, D. (2022). Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19. Biochemical and Biophysical Research Communications; 605: 171-176.
  • Shriwas, P., Roberts, D., Li, Y., Wang, L., Qian, Y., Bergmeier, S., Hines, J., Adhicary, S., Nielsen, C., Chen, X. (2021). A small-molecule pan-class I glucose transporter inhibitor reduces cancer cell proliferation in vitro and tumor growth in vivo by targeting glucose-based metabolism. 14. Cancer Metab; 9.
  • Ghazanfari, D., Noori, M., Bergmeier, S., Hines, J., McCall, K., Goetz, D. (2021). A novel GSK-3 inhibitor binds to GSK-3β via a reversible, time and Cys-199-dependent mechanism.. Bioorganic & medicinal chemistry; 40: 116179.
  • Armstrong, I., Aldhumani, A., Schopis, J., Fang, F., Parsons, E., Zeng, C., Hossain, M., Bergmeier, S., Hines, J. (2020). RNA drug discovery: Conformational restriction enhances specific modulation of the T-box riboswitch function. 20. Bioorganic and Medicinal Chemistry; 28: 7. https://api.elsevier.com/content/abstract/scopus_id/85090049585.
  • Noori, M., Courreges, M., Bergmeier, S., McCall, K., Goetz, D. (2020). Modulation of LPS-induced inflammatory cytokine production by a novel glycogen synthase kinase-3 inhibitor.. European Journal of Pharmacology; 883: 173340.
  • Roberts, D., Wang, L., Zhang, W., Liu, Y., Shriwas, P., Qian, Y., Chen, X., Bergmeier, S. (2020). Isosteres of ester derived glucose uptake inhibitors.. 18. Bioorganic & medicinal chemistry letters; 30: 127406.
  • Noori, M., Bhatt, P., Courreges, M., Ghazanfari, D., Cuckler, C., Orac, C., McMills, M., Schwartz, F., Deosarkar, S., Bergmeier, S., McCall, K., Goetz, D. (2019). Identification of a novel selective and potent inhibitor of glycogen synthase kinase-3. Am J Physiol - Cell Physiol; 317: C1289-C1303.
  • Bergmeier, S., Zheng, Z. (2019). Routes to N-glycinamide oxazolidinone derivatives: The reaction of 4-trityloxymethyl-3- oxa-1-azabicyclo[3.1.0]hexan-2-one with active halides.. 3. Arkivoc; 1-13.
  • Bergmeier, S., Armstrong, I. (2017). Development of a Method for the Synthesis of 4-Aryl-Functionalized 2-Azabicyclo[3.2.1]octanes. 12. Synthesis; 49: 2733-2742. http://dx.doi.org/10.1055/s-0036-1558973.
  • Noori, M., O'Brien, J., Champa, Z., Deosarkar, S., Lanier, O., Qi, C., Burdick, M., Schwartz, F., Bergmeier, S., McCall, K., Goetz, D. (2017). Phenylmethimazole and a Thiazole Derivative of Phenylmethimazole Inhibit IL-6 Expression by Triple Negative Breast Cancer Cells. European Journal of Pharmacology; 803: 130-137. http://www.sciencedirect.com/science/article/pii/S0014299917302182?via%3Dihub.
  • Fang, F., Maciagiewicz, I., Bergmeier, S. (2016). A synthesis of hexahydro H-oxazolo[3,4-a]pyrazin-3-ones from fused aziridines. 1. Heterocycles; 93.
  • Zeng, C., Zhou, S., Bergmeier, S., Hines, J. (2015). Factors that influence T box riboswitch efficacy and tRNA affinity. Bioorganic & Medicinal Chemistry; 23: 5702-5708.
  • Alapati, A., Deosarkar, S., Lanier, O., Qi, C., Carlson, G., Burdick, M., Schwartz, F., McCall, K., Bergmeier, S., Goetz, D. (2015). Simple Modifications to Methimazole that Enhance its Inhibitory Effect on Tumor Necrosis Factor-alpha-Induced Vascular Cell Adhesion Molecule-1 Expression by Human Endothelial Cells. European Journal of Pharmacology; 751: 59-66.
  • Alapati, A., Deosarkar, S., Lanier, O., Qi, C., Carlson, G., Burdick, M., Schwartz, F., McCall, K., Bergmeier, S., Goetz, D. (2015). Simple modifications to methimazole that enhance its inhibitory effect on tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression by human endothelial cells.. European journal of pharmacology; 751: 59-66.
  • Malki, A., Laha, R., Bergmeier, S. (2014). Synthesis and cytotoxic activity of MOM-ether analogs of isosteviol. Elsevier; 24: 1184-1187.
  • Zhou, S., Means, J., Acquaah-Harrison, G., Bergmeier, S., Hines, J. (2012). 1. Characterization of a 1,4-disubstituted 1,2,3-triazole binding to T box antiterminator RNA . Bioorganic and Medicinal Chemistry; 20: 1298-1302.
  • Fang, F., Roberts, D., Zhou, S., Hines, J., Bergmeier, S. (2012). 2. A synthesis of 1,4-disubstituted Imidazolidin-2-ones from fused-ring aziridines I.W. Maciagiewicz. Synthesis; 44: 551-560.
  • Fang, F., Vogel, M., Hines, J., Bergmeier, S. (2012). 3. Fused ring aziridines as a facile entry into triazole fused tricyclic and bicyclic heterocycles . Org. Biomol. Chemistry; 10: 3080-3091.
  • Liu, Y., Cao, Y., Zhang, W., Bergmeier, S., Qin, Y., Akbar, H., Colvin, R., Ding, J., Tong, L., Wu, S., Hines, J., Chen, X. (2012). 4. A small molecule inhibitor of glucose transporter 1 (Glut1) down-regulates glycolysis, induces cell cycle arrest, and inhibits cancer cell growth in vitro and in vivo . Mol. Cancer Ther; 11: 1672-1682.
  • Bergmeier, S., Wells, G., Huang, J., Katz, S. (2012). Studies on the ring opening reactions of 3-oxa-1-azabicyclo[3.1.0]hexan-2-ones. Synthesis of aminomethyl oxazolidinones and aziridinyl ureas. Tetrahedron; 68: 3980-39887.
  • Bergmeier, S. (2012). 3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of human α4β2 neuronal nicotinic acetylcholine receptors. Bioorganic and Medicinal Chemistry Letters; 22: 1797-1813.
  • Bergmeier, S., Huang, J. (2012). An improved synthesis of functionalized cis-dicahydroquinolines using a Baylis- Hillman-type adduct. Heterocycles; 84: 1289-1299.
  • Hurst, W., Krake, S., Bergmeier, S., Payne, M., Miller, K., Stuart, D. (2011). Impact of fermentation, drying, roasting and Dutch processing on flavan-3-ol stereochemistry in cacao beans and cocoa ingredients. . Chemistry Central Journal; 5.
  • Bergmeier, S., McMills, M. (2011). Synthesis of a functionalized oxabicyclo[2.2.1]-heptene-based chemical library. . Combinatorial Chemistry and High-Througput Synthesis; 15: 81-89.
  • Sumskaya, Y., Swain, P., Bergmeier, S., McMills, M., Priestley, N., Wright, D. (2011). Natural feedstocks for diversity-oriented synthesis: macrolide-like scaffolds from nonactate. Arkivoc; 144-166. ://WOS:000290685400013">http://://WOS:000290685400013.
  • Zhou, S., Acquaah-Harrison, G., Bergmeier, S., Hines, J. (2011). Anisotropy studies of tRNA-T box antiterminator RNA complex in the presence of 1,4-disubstituted 1,2,3-triazoles. . Bioorganic and Medicinal Chemistry; 21: 7059-7063.
  • Orac, C., Zhou, S., Means, J., Boehm, D., Bergmeier, S., Hines, J. (2011). Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA. 6786-6795. Journal of Medicinal Chemistry; 54.
  • Henderson, B., Orac, C., Maciagiewicz, I., Bergmeier, S., McKay, D. (2011). 3D-QSAR and 3D-QSSR models of negative allosteric modulators facilitate the design of a novel selective antagonist of human α4β2 neuronal nicotinic acetylcholine receptors. . Bioorganic and Medicinal Chemistry Letters; 21: 1797-1813.
  • Maciagiewicz, I., Zhou, S., Bergmeier, S., Hines, J. (2011). Structure activity studies of RNA-binding oxazolidinone derivatives. . Bioorganic and Medicinal Chemistry Letters; 21: 4524-4527.
  • Phillips, J., Smith, A., Kusche, B., Bessette, B., Swain, P., Bergmeier, S., McMills, M., Wright, D., Priestley, N. (2010). Natural product derivatives with bactericidal activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis. 19. Bioorganic & Medicinal Chemistry Letters; 20: 5936-5938. ://WOS:000281735600073">http://://WOS:000281735600073.
  • Bergmeier, S., Liu, Y., Cao, Y., Zhang, W., Chen, X. (2010). Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms. . Cancer Lett.; 298: 176-185.
  • Bergmeier, S., Krake, S. (2010). Inter- and intramolecular reactions of epoxides and aziridines with pi-nucleophiles. . 37. Tetrahedron; 66: 7337-7360.
  • Bergmeier, S., Hines, J., Zhou, S., Acquaah-Harrison, G. (2010). A library of 1,4-disubstituted 1,2,3-triazole analogs of oxazolidinone RNA-binding agents. . 4. J. Comb. Chem.; 12: 491-496.
  • Bergmeier, S., Orac, C. (2010). Negative Allosteric Modulators that Target Human α4β2 Neuronal Nicotinic Receptors. . J. Pharmaco. Exp. Ther.; 334: 761-774.
  • Bergmeier, S., Zhang, W., Chen, X., Liu, Y. (2010). Novel inhibitors of basal glucose transport as potential anticancer agents. Bioorg Med Chem Lett.; 20: 2191-2194.
  • Luesse, S., Wells, G., Nayek, A., Smith, A., Kusche, B., Bergmeier, S., McMills, M., Priestley, N., Wright, D. (2008). Natural products in parallel synthesis: Triazole libraries of nonactic acid. 14. Bioorganic & Medicinal Chemistry Letters; 18: 3946-3949. ://WOS:000257640400025">http://://WOS:000257640400025.
  • Nikodinovic, J., Dinges, J., Bergmeier, S., McMills, M., Wright, D., Priestley, N. (2006). Resolution of methyl nonactate by Rhodococcus erythropolis under aerobic and anaerobic conditions. 3. Organic Letters; 8: 443-445. ://WOS:000235120700023">http://://WOS:000235120700023.

Journal Article, Professional Journal (1)

  • McMills, M., Bergmeier, S. (2010). Natural Prtoduct Derivatives with Bactericidal Activity Against Gram-positive Pathogens Including Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococcus faecalis. 19. Bioorganic and Medicinal Chemistry Letters/Elsevier; 20: 5936-5938.

Patent (10)

  • Goetz, D., Begmeier, S., McMills, M., Orac, C. Imidazole and thiazole compositions for modifying biological signaling . 10,633,377.
  • Goetz, D., Bergmeier, S., McMills, M., Orac, C. Imidazole and thiazole compositions for modifying biological signaling -B. 10,407,420.
  • Goetz, D., Bergmeier, S., McMills, M., Orac, C. Imidazole and thiazole compositions for modifying biological signaling - C . Application # 20200017489.
  • McMills, M., Goetz, D., Bergmeier, S., Orac, C. Imidazole and Thiazole Compositions for Modifying Biological Signaling . 10,023,567.
  • Bergmeier, S., Chen, X. Compositions and methods for glucose transport inhibition. US 10,000,443, B2.
  • Bergmeier, S., Chen, X. Compositions and Methods for Glucose Transport Inhibition. US Patent 9181162.
  • Goetz, D., McCall, K., Bergmeier, S., Schwartz, F., Bhatt, P., Deosarkar, S. Methods and compositions to modify GSK-3 activity.
  • Bergmeier, S., Goetz, D., McMall, K. A method to modify the activity of GSK-3.
  • Bergmeier, S., Goetz, D., McMall, K. Use of phenylmethyimazole for the prevention and treatment of fatty liver disease.
  • Bergmeier, S., Goetz, D., McMills, M., McMall, K. Compositions that modify biological signaling.

Book, Chapter in Scholarly Book (3)

  • Bergmeier, S. (2013). Three-membered ring systems. Elsevier; 25: 47-70.
  • Bergmeier, S. (2011). Three-membered ring systems. Progress in Heterocyclic Chemistry; 23: 75-100.
  • Bergmeier, S., Lapinsky, D. (2010). Three-membered ring systems. . Progress in Heterocyclic Chemistry; 22: 59-83.